SUPERNUS PHARMACEUTICALS, INC. (SUPN)

SEC filing

SUPERNUS PHARMACEUTICALS, INC.

SUPN · CIK 1356576

4 · Feb 23, 2026 · Sensenig Bethany sold 4,475 shares at $51.01/share ($228.3K); exercised options for 4,475 shares

Sensenig Bethany sold 4,475 shares at $51.01/share ($228.3K); exercised options for 4,475 shares

FORM 4

xslF345X05/wk-form4_1771882782.xmlSEC.gov

Graphics and non-inline formats (not embedded below).